Q3 2026 Management View Brian Tyler, CEO & Director, emphasized the company's continued momentum in oncology, biopharma services, and North American distribution, stating, "Revenue and adjusted EPS ...
Bengaluru: Commuting on the 6km Bommasandra-Jigani industrial corridor, home to some of the city's largest pharmaceutical and ...
Lehigh Carbon Community College is poised to become the hub of pharmaceutical workforce development in Pennsylvania. Following an announcement by Gov. Josh Shapiro at the Da Vinci Science Center, ...
Pharmaceutical Technology on MSN
Why pharma manufacturers are still investing in Europe
Despite being saddled with tariffs and lagging behind China and the US, European sites offer biopharma suppliers a chance to ...
AppLovin Corporation (NASDAQ:APP) is one of the 10 AI Stocks Analysts Are Watching. On February 2, Benchmark analyst Mike Hickey reiterated a Buy rating on the stock with a $775.00 price target.
The confluence of China’s rapidly rising biotech prowess and US policy decisions that hamper the industry is a cause for ...
AppLovin's stock faced a severe decline of over 16% as investor fears regarding AI-driven disruptions in mobile advertising ...
British pharmaceutical group GSK reported Wednesday a sharp rise in annual net profit, boosted by strong sales of HIV, respiratory and cancer treatments as it recovered from costly US lawsuits over ...
CC Pharma’s selection as a TOP 100 Innovator reflects its disciplined innovation strategy, strong regional footprint, and commitment to operational excellence in a highly regulated market. The award ...
The Higher Education Commission (HEC) of Pakistan has launched the National Skill Competency Test for IT students to better align university education ...
Relay Therapeutics has received the FDA BTD for zovegalisib, along with fulvestrant, for HR+/HER2- advanced breast cancer treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results